European survey of oncology patients’ experience of breakthrough pain (Phase III)

The objectives of the study are to determine: 

  • Oncology patients’ experiences of breakthrough pain. 

  • Oncology patients’ experiences of breakthrough pain medication. 

  • Oncology patients’ views about forthcoming breakthrough medications. 


  • Associate Professor Odette Spruyt 

Principal investigators 

  • International lead: Dr Andrew Davies 

  • Royal Marsden Hospital, Surrey, UK. 

  • Peter Mac Principal Investigator: A/Prof Odette Spruyt - Palliative care consultant 


Associate Professor Odette Spruyt - Principal Investigator 

  • Email: This email address is being protected from spambots. You need JavaScript enabled to view it. 

Project status 

  • Completed